NCT04643730 is a NA clinical trial of Acupressure methods in Interventions Pain, sponsored by Eskisehir Osmangazi University.

Who is sponsoring NCT04643730?

NCT04643730 is sponsored by Eskisehir Osmangazi University.

What drugs are being tested in NCT04643730?

Interventions in NCT04643730: Acupressure methods, Foot Reflexology Methods, Control Grup.

What condition does NCT04643730 study?

NCT04643730 studies Interventions Pain.

Is NCT04643730 still recruiting?

NCT04643730 is currently completed. Last updated 25 November 2020.

Last reviewed 2020-11-25 · How we verify

NCT04643730

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects on Pain of Acupressure and Foot Reflexology Before Heel Lancing in Newborns

Completed NA Last updated 25 November 2020

What this trial tests

NA trial testing Acupressure methods in Interventions Pain in 105 participants. Completed in 30 March 2018.

Timeline

30 October 2017

Primary endpoint
30 March 2018

30 March 2018

Quick facts

Lead sponsor	Eskisehir Osmangazi University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	prevention
Enrollment	105
Start date	30 October 2017
Primary completion	30 March 2018
Estimated completion	30 March 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Acupressure methods
Foot Reflexology Methods
Control Grup

Conditions studied

Interventions Pain — all drugs for Interventions Pain →

Sponsor

Eskisehir Osmangazi University

Who can join

24 Hours and older, any sex, with Interventions Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to determine the effects of foot reflexology and acupressure on the KI3 and St36 points on pain during interventions when these procedures were administered before heel lancing in term newborns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Eskisehir Osmangazi University trials

Trials by the same sponsor.

NCT07343505 — Environmental Enrichment Intervention and Brain Development in Preterm Infants · NA · not yet recruiting
NCT07346963 — RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV · not yet recruiting
NCT07342101 — Evaluating the LGG of on Acute Infectious Diarrhea in Children · NA · not yet recruiting
NCT07307924 — The Effect of Motivational Interviewing on Knowledge, Self-Efficacy, and Treatment Adherence in Patients With Primary Hy · NA · enrolling by invitation
NCT07131267 — Evaluating Sexual Functioning in Trans Men During the Gender Affirmation Process: A Mixed Methods Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04643730 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eskisehir Osmangazi University
Last refreshed: 25 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04643730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing